United Therapeutics CEO Martine A. Rothblatt reports $5.51 million common share sale
UTHR•United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on Nov. 17, 2026, and exercised options for 9,500 shares at $117.76 per share.
1. Share transactions
Rothblatt sold 9,500 common shares and exercised stock options for 9,500 common shares at $117.76 per share on Nov. 17, 2026. After the transactions, the transacting trusts held 324,443 common shares, while her direct holdings totaled 40,513 shares.




